Normal view
-
JAMA Health Forum New Online
-
Poor Mental Health and the Use of Buy Now, Pay Later Loans
This cross-sectional study examines the association between buy now, pay later loans and probable depression, anxiety, and posttraumatic stress.
Poor Mental Health and the Use of Buy Now, Pay Later Loans
-
Journal of Medical Internet Research
-
Stakeholder Criteria for Trust in Artificial IntelligenceβBased Computer Perception Tools in Health Care: Qualitative Interview Study
Background: Computer perception (CP) technologies hold significant promise for advancing precision mental health care systems, given their ability to leverage algorithmic analysis of continuous, passive sensing data from wearables and smartphones (eg, behavioral activity, geolocation, vocal features, and ambient environmental data) to infer clinically meaningful behavioral and physiological states. However, successful implementation critically depends on cultivating well-founded stakeholder trus
Stakeholder Criteria for Trust in Artificial IntelligenceβBased Computer Perception Tools in Health Care: Qualitative Interview Study
-
npj Digital Medicine
-
Legal implications of AI standard of care integration on patientsβ informed consent: lessons from surgery
npj Digital Medicine, Published online: 13 December 2025; doi:10.1038/s41746-025-02157-1Legal implications of AI standard of care integration on patientsβ informed consent: lessons from surgery
Legal implications of AI standard of care integration on patientsβ informed consent: lessons from surgery
npj Digital Medicine, Published online: 13 December 2025; doi:10.1038/s41746-025-02157-1
Legal implications of AI standard of care integration on patientsβ informed consent: lessons from surgery-
AI News

-
AI in 2026: Experimental AI concludes as autonomous systems rise
Generative AIβs experimental phase is concluding, making way for truly autonomous systems in 2026 that act rather than merely summarise. 2026 will lose the focus on model parameters and be about agency, energy efficiency, and the ability to navigate complex industrial environments. The next twelve months represent a departure from chatbots toward autonomous systems executing workflows with minimal oversight; forcing organisations to rethink infrastructure, governance, and talent management.
AI in 2026: Experimental AI concludes as autonomous systems rise
Generative AIβs experimental phase is concluding, making way for truly autonomous systems in 2026 that act rather than merely summarise.
2026 will lose the focus on model parameters and be about agency, energy efficiency, and the ability to navigate complex industrial environments. The next twelve months represent a departure from chatbots toward autonomous systems executing workflows with minimal oversight; forcing organisations to rethink infrastructure, governance, and talent management.
Autonomous AI systems take the wheel
Hanen Garcia, Chief Architect for Telecommunications at Red Hat, argues that while 2025 was defined by experimentation, the coming year marks a βdecisive pivot towards agentic AI, autonomous software entities capable of reasoning, planning, and executing complex workflows without constant human intervention.β
Telecoms and heavy industry are the proving grounds. Garcia points to a trajectory toward autonomous network operations (ANO), moving beyond simple automation to self-configuring and self-healing systems. The business goal is to reverse commoditisation by βprioritising intelligence over pure infrastructureβ and reduce operating expenditures.
Technologically, service providers are deploying multiagent systems (MAS). Rather than relying on a single model, these allow distinct agents to collaborate on multi-step tasks, handling complex interactions autonomously. However, increased autonomy introduces new threats.
Emmet King, Founding Partner of J12 Ventures, warns that βas AI agents gain the ability to autonomously execute tasks, hidden instructions embedded in images and workflows become potential attack vectors.β Security priorities must therefore shift from endpoint protection to βgoverning and auditing autonomous AI actions.β
As organisations scale these autonomous AI workloads, they hit a physical wall: power.
King argues energy availability, rather than model access, will determine which startups scale. βCompute scarcity is now a function of grid capacity,β King states, suggesting energy policy will become the de facto AI policy in Europe.
KPIs must adapt. Sergio Gago, CTO at Cloudera, predicts enterprises will prioritise energy efficiency as a primary metric. βThe new competitive edge wonβt come from the largest models, but from the most intelligent, efficient use of resources.β
Horizontal copilots lacking domain expertise or proprietary data will fail ROI tests as buyers measure real productivity. The βclearest enterprise ROIβ will emerge from manufacturing, logistics, and advanced engineeringβsectors where AI integrates into high-value workflows rather than consumer-facing interfaces.
AI ends the static app in 2026
Software consumption is changing too. Chris Royles, Field CTO for EMEA at Cloudera, suggests the traditional concept of an βappβ is becoming fluid. βIn 2026, AI will start to radically change the way we think about apps, how they function and how theyβre built.β
Users will soon request temporary modules generated by code and a prompt, effectively replacing dedicated applications. βOnce that function has served its purpose, it closes,β Royles explains, noting these βdisposableβ apps can be built and rebuilt in seconds.
Rigorous governance is required here; organisations need visibility into the reasoning processes used to create these modules to ensure errors are corrected safely.
Data storage faces a similar reckoning, especially as AI becomes more autonomous. Wim Stoop, Director of Product Marketing at Cloudera, believes the era of βdigital hoardingβ is ending as storage capacity hits its limit.
βAI-generated data will become disposable, created and refreshed on demand rather than stored indefinitely,β Stoop predicts. Verified, human-generated data will rise in value while synthetic content is discarded.
Specialist AI governance agents will pick up the slack. These βdigital colleaguesβ will continuously monitor and secure data, allowing humans to βgovern the governanceβ rather than enforcing individual rules. For example, a security agent could automatically adjust access permissions as new data enters the environment without human intervention.
Sovereignty and the human element
Sovereignty remains a pressing concern for European IT. Red Hatβs survey data indicates 92 percent of IT and AI leaders in EMEA view enterprise open-source software as vital for achieving sovereignty. Providers will leverage existing data centre footprints to offer sovereign AI solutions, ensuring data remains within specific jurisdictions to meet compliance demands.
Emmet King, Founding Partner of J12 Ventures, adds that competitive advantage is moving from owning models to βcontrolling training pipelines and energy supply,β with open-source advancements allowing more actors to run frontier-scale workloads.
Workforce integration is becoming personal. Nick Blasi, Co-Founder of Personos, argues tools ignoring human nuance β tone, temperament, and personality β will soon feel obsolete. By 2026, Blasi predicts βhalf of workplace conflict will be flagged by AI before managers know it exists.β
These systems will focus on βcommunication, influence, trust, motivation, and conflict resolution,β Blasi suggests, adding that personality science will become the βoperating systemβ for the next generation of autonomous AI, offering grounded understanding of human individuality rather than generic recommendations.
The era of the βthin wrapperβ is over. Buyers are now measuring real productivity, exposing tools built on hype rather than proprietary data. For the enterprise, competitive advantage will no longer come from renting access to a model, but from controlling the training pipelines and energy supply that power it.
See also: BBVA embeds AI into banking workflows using ChatGPT Enterprise

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx and is co-located with other leading technology events. Click here for more information.
AI News is powered by TechForge Media. Explore other upcoming enterprise technology events andΒ webinars here.
The post AI in 2026: Experimental AI concludes as autonomous systems rise appeared first on AI News.
-
Nature - Issue - nature.com science feeds
-
China leads research in 90% of crucial technologies β a dramatic shift this century
Nature, Published online: 12 December 2025; doi:10.1038/d41586-025-04048-7The United States tops the remaining areas in an assessment of 74 technologies.
China leads research in 90% of crucial technologies β a dramatic shift this century
Nature, Published online: 12 December 2025; doi:10.1038/d41586-025-04048-7
The United States tops the remaining areas in an assessment of 74 technologies.-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Mapping the inflammatory origins of lung cancer
Cancer Cell. 2025 Dec 11:S1535-6108(25)00498-2. doi: 10.1016/j.ccell.2025.11.005. Online ahead of print.ABSTRACTHow early precursor cells and their surrounding microenvironment cooperate to drive oncogenic progression in lung adenocarcinoma (LUAD) remains elusive. In this issue of Cancer Cell, Peng et al. conducted multimodal spatial-omics to comprehensively profile precancerous lung and LUAD tissues, uncovering alveolar progenitors and proinflammatory niches that co-evolve during cancer progres
Mapping the inflammatory origins of lung cancer
Cancer Cell. 2025 Dec 11:S1535-6108(25)00498-2. doi: 10.1016/j.ccell.2025.11.005. Online ahead of print.
ABSTRACT
How early precursor cells and their surrounding microenvironment cooperate to drive oncogenic progression in lung adenocarcinoma (LUAD) remains elusive. In this issue of Cancer Cell, Peng et al. conducted multimodal spatial-omics to comprehensively profile precancerous lung and LUAD tissues, uncovering alveolar progenitors and proinflammatory niches that co-evolve during cancer progression.
PMID:41386222 | DOI:10.1016/j.ccell.2025.11.005
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Application progress of spatial omics in hepatobiliary tumor research
Hepatobiliary Surg Nutr. 2025 Dec 1;14(6):1028-1030. doi: 10.21037/hbsn-2025-aw-862. Epub 2025 Nov 25.NO ABSTRACTPMID:41383666 | PMC:PMC12690317 | DOI:10.21037/hbsn-2025-aw-862
Application progress of spatial omics in hepatobiliary tumor research
Hepatobiliary Surg Nutr. 2025 Dec 1;14(6):1028-1030. doi: 10.21037/hbsn-2025-aw-862. Epub 2025 Nov 25.
NO ABSTRACT
PMID:41383666 | PMC:PMC12690317 | DOI:10.21037/hbsn-2025-aw-862
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Exploring the role of lipid metabolism genes in gastric cancer prognosis and tumor immune microenvironment
J Int Med Res. 2025 Dec;53(12):3000605251403252. doi: 10.1177/03000605251403252. Epub 2025 Dec 11.ABSTRACTBackgroundGastric cancer remains a major global health challenge due to its high mortality rate and complex pathophysiological mechanisms. Emerging evidence highlights that dysregulated lipid metabolism contributes to gastric cancer progression and prognosis, but the associations between lipid metabolism-associated genes, gastric cancer patient survival, and tumor immune microenvironment rem
Exploring the role of lipid metabolism genes in gastric cancer prognosis and tumor immune microenvironment
J Int Med Res. 2025 Dec;53(12):3000605251403252. doi: 10.1177/03000605251403252. Epub 2025 Dec 11.
ABSTRACT
BackgroundGastric cancer remains a major global health challenge due to its high mortality rate and complex pathophysiological mechanisms. Emerging evidence highlights that dysregulated lipid metabolism contributes to gastric cancer progression and prognosis, but the associations between lipid metabolism-associated genes, gastric cancer patient survival, and tumor immune microenvironment remodeling are not fully elucidated.MethodsWe analyzed publicly available omics and clinical data, including RNA sequencing data from 371 gastric cancer samples in The Cancer Genome Atlas database and 433 gastric cancer samples in the Gene Expression Omnibus database. We first curated the top 100 lipid metabolism-associated genes based on relevance scores. Then, univariate Cox regression was used to identify genes significantly associated with overall survival. Consensus clustering was applied to these survival-related genes to define gastric cancer molecular subtypes. Copy number variation analysis was performed to assess genomic alterations of these genes in tumor samples. A prognostic risk model was constructed using least absolute shrinkage and selection operator regression and validated via multivariate Cox regression. Immune infiltration analysis using CIBERSORT and ESTIMATE algorithms was conducted to explore associations between lipid metabolism-associated genes and tumor immune microenvironment characteristics.ResultsA total of 3911 differentially expressed genes were identified between gastric cancer and adjacent normal tissues. Among the top 100 lipid metabolism-associated genes, 43 were significantly linked to patient survival, most of which were considered as poor prognostic factors. Copy number variation analysis revealed frequent copy number gains of these genes in tumor samples. Consensus clustering stratified patients into two molecular subtypes (LMAGcluster A and LMAGcluster B), with LMAGcluster A showing significantly worse survival outcomes (median survival: 2.6 years vs. 8.3 years in LMAGcluster B, p < 0.001). LMAGcluster A was also characterized by elevated infiltration of pro-tumor immune cells, such as regulatory T cells and follicular helper T cells. The prognostic model based on 14 key lipid metabolism-associated genes exhibited robust predictive performance, with area under the receiver operating characteristic curve values of 0.702-0.761 in The Cancer Genome Atlas cohort and 0.621-0.638 in the Gene Expression Omnibus cohort for 1-, 3-, and 5-year survival.ConclusionLipid metabolism-associated genes are closely associated with gastric cancer prognosis and tumor immune microenvironment remodeling. The identified gene-based molecular subtypes and prognostic model provide novel insights into gastric cancer progression, and the 14 key genes may serve as potential biomarkers and therapeutic targets.
PMID:41381057 | DOI:10.1177/03000605251403252
-
Latest Science News -- ScienceDaily
-
AI finds a surprising monkeypox weak spot that could rewrite vaccines
Researchers used AI to pinpoint a little-known monkeypox protein that provokes strong protective antibodies. When the team tested this protein as a vaccine ingredient in mice, it produced a potent immune response. The discovery could lead to simpler, more effective mpox vaccines and therapies. It may also help guide future efforts against smallpox.
AI finds a surprising monkeypox weak spot that could rewrite vaccines
-
Nature Medicine
-
Cancer screening must become more precise
Nature Medicine, Published online: 12 December 2025; doi:10.1038/s41591-025-04148-xTo improve early detection, cancer screening studies need to evolve and integrate multimodal data in the identification of high-risk individuals.
Cancer screening must become more precise
Nature Medicine, Published online: 12 December 2025; doi:10.1038/s41591-025-04148-x
To improve early detection, cancer screening studies need to evolve and integrate multimodal data in the identification of high-risk individuals.-
TechCrunch
-
Trumpβs AI executive order promises βone rulebookβ β startups may get legal limbo instead
Trump signed an AI executive order targeting state laws and promising one national rulebook. Critics warn it could trigger court battles and prolong uncertainty for startups while Congress debates federal rules.
Trumpβs AI executive order promises βone rulebookβ β startups may get legal limbo instead
-
MRD
-
Minimal Residual Disease Detection: Bridging Molecular and Clinical Strategies for Recurrence Prevention in Gynecologic Cancers
Int J Mol Sci. 2025 Dec 3;26(23):11708. doi: 10.3390/ijms262311708.ABSTRACTGynecologic cancers remain a major global health burden, particularly in low- and middle-income countries, with high incidence and mortality rates around 45-50%. The detection of minimal residual disease (MRD) is transforming the management of recurrence risk in gynecologic cancers through highly sensitive molecular technologies. MRD encompasses small populations of residual cancer cells or post-treatment molecular traces
Minimal Residual Disease Detection: Bridging Molecular and Clinical Strategies for Recurrence Prevention in Gynecologic Cancers
Int J Mol Sci. 2025 Dec 3;26(23):11708. doi: 10.3390/ijms262311708.
ABSTRACT
Gynecologic cancers remain a major global health burden, particularly in low- and middle-income countries, with high incidence and mortality rates around 45-50%. The detection of minimal residual disease (MRD) is transforming the management of recurrence risk in gynecologic cancers through highly sensitive molecular technologies. MRD encompasses small populations of residual cancer cells or post-treatment molecular traces but remain undetectable by conventional methods. Its detection relies on circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and advanced next-generation sequencing (NGS), with ctDNA-based MRD assays having sensitivity levels between 85% and over 99%. Other technologies, such as liquid biopsies and digital PCR, are also in development. MRD status has demonstrated high predictors of recurrence and survival with positive MRD strongly associated with poor outcomes and negative MRD indicates sustained remission. However, MRD detection faces significant limitations, such as tumor heterogeneity, inconstant ctDNA levels, technical issues of false-negative results, and limited clinical accessibility. Therefore, this review presents current evidence regarding the molecular detection of MRD in gynecologic malignancies and assesses its prognostic and predictive relevance. Ultimately, MRD continuous integration into clinical practice offers a promising modality to enable early relapse detection, more precise therapeutic decision-making, and the improvement of personalized medicine access to gynecologic cancers worldwide.
PMID:41373852 | PMC:PMC12692091 | DOI:10.3390/ijms262311708
-
cs.AI, q-bio.NC updates on arXiv.org
-
Exploring Health Misinformation Detection with Multi-Agent Debate
arXiv:2512.09935v1 Announce Type: new Abstract: Fact-checking health-related claims has become increasingly critical as misinformation proliferates online. Effective verification requires both the retrieval of high-quality evidence and rigorous reasoning processes. In this paper, we propose a two-stage framework for health misinformation detection: Agreement Score Prediction followed by Multi-Agent Debate. In the first stage, we employ large language models (LLMs) to independently evaluate retr
Exploring Health Misinformation Detection with Multi-Agent Debate
-
cs.AI, q-bio.NC updates on arXiv.org
-
Mind the Gap! Pathways Towards Unifying AI Safety and Ethics Research
arXiv:2512.10058v1 Announce Type: new Abstract: While much research in artificial intelligence (AI) has focused on scaling capabilities, the accelerating pace of development makes countervailing work on producing harmless, "aligned" systems increasingly urgent. Yet research on alignment has diverged along two largely parallel tracks: safety--centered on scaled intelligence, deceptive or scheming behaviors, and existential risk--and ethics--focused on present harms, the reproduction of social bi
Mind the Gap! Pathways Towards Unifying AI Safety and Ethics Research
-
cs.AI, q-bio.NC updates on arXiv.org
-
Robust AI Security and Alignment: A Sisyphean Endeavor?
arXiv:2512.10100v1 Announce Type: new Abstract: This manuscript establishes information-theoretic limitations for robustness of AI security and alignment by extending G\"odel's incompleteness theorem to AI. Knowing these limitations and preparing for the challenges they bring is critically important for the responsible adoption of the AI technology. Practical approaches to dealing with these challenges are provided as well. Broader implications for cognitive reasoning limitations of AI systems
Robust AI Security and Alignment: A Sisyphean Endeavor?
-
cs.AI, q-bio.NC updates on arXiv.org
-
Phythesis: Physics-Guided Evolutionary Scene Synthesis for Energy-Efficient Data Center Design via LLMs
arXiv:2512.10611v1 Announce Type: new Abstract: Data center (DC) infrastructure serves as the backbone to support the escalating demand for computing capacity. Traditional design methodologies that blend human expertise with specialized simulation tools scale poorly with the increasing system complexity. Recent studies adopt generative artificial intelligence to design plausible human-centric indoor layouts. However, they do not consider the underlying physics, making them unsuitable for the DC
Phythesis: Physics-Guided Evolutionary Scene Synthesis for Energy-Efficient Data Center Design via LLMs
-
cs.AI, q-bio.NC updates on arXiv.org
-
IoTEdu: Access Control, Detection, and Automatic Incident Response in Academic IoT Networks
arXiv:2512.09934v1 Announce Type: cross Abstract: The growing presence of IoT devices in academic environments has increased operational complexity and exposed security weaknesses, especially in academic institutions without unified policies for registration, monitoring, and incident response involving IoT. This work presents IoTEdu, an integrated platform that combines access control, incident detection, and automatic blocking of IoT devices. The solution was evaluated in a controlled environm
IoTEdu: Access Control, Detection, and Automatic Incident Response in Academic IoT Networks
-
cs.AI, q-bio.NC updates on arXiv.org
-
MedXAI: A Retrieval-Augmented and Self-Verifying Framework for Knowledge-Guided Medical Image Analysis
arXiv:2512.10098v1 Announce Type: cross Abstract: Accurate and interpretable image-based diagnosis remains a fundamental challenge in medical AI, particularly un- der domain shifts and rare-class conditions. Deep learning mod- els often struggle with real-world distribution changes, exhibit bias against infrequent pathologies, and lack the transparency required for deployment in safety-critical clinical environments. We introduce MedXAI (An Explainable Framework for Med- ical Imaging Classifica
MedXAI: A Retrieval-Augmented and Self-Verifying Framework for Knowledge-Guided Medical Image Analysis
-
Cell
-
Are ultrasensitive ctDNA assays ready for clinical use in early-stage NSCLC?
Disease recurrence in early-stage non-small cell lung cancer (NSCLC) remains a persistent clinical challenge, underscoring the need for better prognostic biomarkers. In this preview, we highlight the clinical implications of ultrasensitive ctDNA monitoring in lung cancer risk modeling reported by Black et al. in this issue of Cell.